Barrett esophagus

References

• Kahrilas PJ. The problems with surveillance of Barrett’s esophagus. N Engl J Med 2011; 365:1437 - 8; http://dx.doi.org/10.1056/NEJMe1108435; PMID: 21995392
   PubMed Web of Science ®Google Scholar
• Xian W, Ho KY, Crum CP, McKeon F. Cellular origin of Barrett’s esophagus: controversy and therapeutic implications. Gastroenterology 2012; 142:1424 - 30; http://dx.doi.org/10.1053/j.gastro.2012.04.028; PMID: 22537611
   PubMed Web of Science ®Google Scholar
• Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012; 21:36 - 51; http://dx.doi.org/10.1016/j.ccr.2011.12.004; PMID: 22264787
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett’s esophagus. Gastroenterology 2010; 138:854 - 69; http://dx.doi.org/10.1053/j.gastro.2010.01.002; PMID: 20080098
   PubMed Web of Science ®Google Scholar
• Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009; 136:376 - 86; http://dx.doi.org/10.1053/j.gastro.2008.12.015; PMID: 19124023
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus?. Gastroenterology 2000; 119:333 - 8; http://dx.doi.org/10.1053/gast.2000.9302; PMID: 10930368
   PubMed Web of Science ®Google Scholar
• Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 2011; 365:1375 - 83; http://dx.doi.org/10.1056/NEJMoa1103042; PMID: 21995385
   PubMed Web of Science ®Google Scholar
• Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011; 103:1049 - 57; http://dx.doi.org/10.1093/jnci/djr203; PMID: 21680910
   PubMed Web of Science ®Google Scholar
• Moyes LH, Going JJ. Still waiting for predictive biomarkers in Barrett’s oesophagus. J Clin Pathol 2011; 64:742 - 50; http://dx.doi.org/10.1136/jclinpath-2011-200084; PMID: 21606229
   PubMed Web of Science ®Google Scholar
• Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, Ritter MP, et al. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998; 2:260 - 8; http://dx.doi.org/10.1016/S1091-255X(98)80021-8; PMID: 9841983
   PubMedGoogle Scholar
• Barrett NR. Chronic peptic ulcer of the oesophagus and ‘oesophagitis’. Br J Surg 1950; 38:175 - 82; http://dx.doi.org/10.1002/bjs.18003815005; PMID: 14791960
   PubMed Web of Science ®Google Scholar
• Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett’s esophagus. N Engl J Med 1976; 295:476 - 80; http://dx.doi.org/10.1056/NEJM197608262950904; PMID: 940579
   PubMed Web of Science ®Google Scholar
• Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R, et al. Residual embryonic cells as precursors of a Barrett’s-like metaplasia. Cell 2011; 145:1023 - 35; http://dx.doi.org/10.1016/j.cell.2011.05.026; PMID: 21703447
   PubMed Web of Science ®Google Scholar
• Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124:823 - 35; http://dx.doi.org/10.1016/j.cell.2006.02.016; PMID: 16497591
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454:436 - 44; http://dx.doi.org/10.1038/nature07205; PMID: 18650914
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317:121 - 4; http://dx.doi.org/10.1126/science.1140485; PMID: 17615358
   PubMed Web of Science ®Google Scholar
• Grivennikov S, Karin M. Autocrine IL-6 signaling: a key event in tumorigenesis?. Cancer Cell 2008; 13:7 - 9; http://dx.doi.org/10.1016/j.ccr.2007.12.020; PMID: 18167335
   PubMed Web of Science ®Google Scholar
• Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1:3 - 19; http://dx.doi.org/10.1038/sj.gene.6363645; PMID: 11197303
   PubMed Web of Science ®Google Scholar
• Howell WM, Calder PC, Grimble RF. Gene polymorphisms, inflammatory diseases and cancer. Proc Nutr Soc 2002; 61:447 - 56; http://dx.doi.org/10.1079/PNS2002186; PMID: 12691174
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut 2002; 51:316 - 22; http://dx.doi.org/10.1136/gut.51.3.316; PMID: 12171950
   PubMed Web of Science ®Google Scholar
• Tatsuta T, Mukaisho K, Sugihara H, Miwa K, Tani T, Hattori T. Expression of Cdx2 in early GRCL of Barrett’s esophagus induced in rats by duodenal reflux. Dig Dis Sci 2005; 50:425 - 31; http://dx.doi.org/10.1007/s10620-005-2452-9; PMID: 15810620
   PubMed Web of Science ®Google Scholar
• Sarosi G, Brown G, Jaiswal K, Feagins LA, Lee E, Crook TW, et al. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus. Dis Esophagus 2008; 21:43 - 50; PMID: 18197938
   PubMed Web of Science ®Google Scholar
• Theisen J, Peters JH, Fein M, Hughes M, Hagen JA, Demeester SR, et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg 2005; 241:63 - 8; PMID: 15621992
   PubMed Web of Science ®Google Scholar
• Cheng P, Gong J, Wang T, Jie C, Liu GS, Zhang R. Gene expression in Barrett’s esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats. World J Gastroenterol 2005; 11:3277 - 80; PMID: 15929182
   PubMed Web of Science ®Google Scholar
• Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett’s epithelium. Gut 2006; 55:16 - 25; http://dx.doi.org/10.1136/gut.2005.066209; PMID: 16118348
   PubMed Web of Science ®Google Scholar
• Szentpáli K, Széll M, Paszt A, Wolfárd A, Dobozy A, Németh I, et al. Simultaneous adeno- and squamous cell carcinoma with different phenotypic profiles in a rat model of chronic gastroesophageal reflux. Dis Esophagus 2007; 20:305 - 10; http://dx.doi.org/10.1111/j.1442-2050.2007.00682.x; PMID: 17617879
   PubMed Web of Science ®Google Scholar
• Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ. Histopathologic evaluation of an animal model for Barrett’s esophagus and adenocarcinoma of the distal esophagus. J Surg Res 2006; 135:337 - 44; http://dx.doi.org/10.1016/j.jss.2006.04.023; PMID: 16926029
   PubMed Web of Science ®Google Scholar
• Kaur BS, Triadafilopoulos G. Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett’s esophagus are COX-2 and PKC-epsilon dependent. Am J Physiol Gastrointest Liver Physiol 2002; 283:G327 - 34; PMID: 12121879
   PubMedGoogle Scholar
• Souza RF, Krishnan K, Spechler SJ. Acid, bile, and CDX: the ABCs of making Barrett’s metaplasia. Am J Physiol Gastrointest Liver Physiol 2008; 295:G211 - 8; http://dx.doi.org/10.1152/ajpgi.90250.2008; PMID: 18556417
   PubMed Web of Science ®Google Scholar
• Theisen J, Nehra D, Citron D, Johansson J, Hagen JA, Crookes PF, et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 2000; 4:50 - 4; http://dx.doi.org/10.1016/S1091-255X(00)80032-3; PMID: 10631362
   PubMed Web of Science ®Google Scholar
• Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154:965 - 73; http://dx.doi.org/10.1016/S0002-9440(10)65346-1; PMID: 10233832
   PubMed Web of Science ®Google Scholar
• Guy NC, Garewal H, Holubec H, Bernstein H, Payne CM, Bernstein C, et al. A novel dietary-related model of esophagitis and Barrett’s esophagus, a premalignant lesion. Nutr Cancer 2007; 59:217 - 27; http://dx.doi.org/10.1080/01635580701499529; PMID: 18001217
   PubMed Web of Science ®Google Scholar
• Eda A, Osawa H, Satoh K, Yanaka I, Kihira K, Ishino Y, et al. Aberrant expression of CDX2 in Barrett’s epithelium and inflammatory esophageal mucosa. J Gastroenterol 2003; 38:14 - 22; http://dx.doi.org/10.1007/s005350300001; PMID: 12560917
   PubMed Web of Science ®Google Scholar
• Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2011; 9:220 - 7; http://dx.doi.org/10.1016/j.cgh.2010.11.008
   PubMed Web of Science ®Google Scholar
• Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett’s esophagus. Gastroenterology 2010; 138:2260 - 6; http://dx.doi.org/10.1053/j.gastro.2010.02.045; PMID: 20188100
   PubMed Web of Science ®Google Scholar
• Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Färkkilä M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61:6 - 13; http://dx.doi.org/10.1159/000007730; PMID: 10671769
   PubMed Web of Science ®Google Scholar
• Abrams JA, Fields S, Lightdale CJ, Neugut AI. Racial and ethnic disparities in the prevalence of Barrett’s esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol 2008; 6:30 - 4; http://dx.doi.org/10.1016/j.cgh.2007.10.006; PMID: 18063419
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129:1825 - 31; http://dx.doi.org/10.1053/j.gastro.2005.08.053; PMID: 16344051
   PubMed Web of Science ®Google Scholar
• Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology 1999; 117:327 - 35; http://dx.doi.org/10.1053/gast.1999.0029900327; PMID: 10419913
   PubMed Web of Science ®Google Scholar
• Cooper BT, Chapman W, Neumann CS, Gearty JC. Continuous treatment of Barrett’s oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006; 23:727 - 33; http://dx.doi.org/10.1111/j.1365-2036.2006.02825.x; PMID: 16556174
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett’s esophagus. Am J Gastroenterol 2004; 99:1877 - 83; http://dx.doi.org/10.1111/j.1572-0241.2004.30228.x; PMID: 15447744
   PubMed Web of Science ®Google Scholar
• El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci 2008; 53:2307 - 12; http://dx.doi.org/10.1007/s10620-008-0413-9; PMID: 18651221
   PubMed Web of Science ®Google Scholar
• Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett’s oesophagus. Aliment Pharmacol Ther 2008; 27:321 - 6; http://dx.doi.org/10.1111/j.1365-2036.2007.03579.x; PMID: 18047565
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825 - 31; http://dx.doi.org/10.1056/NEJM199903183401101; PMID: 10080844
   PubMed Web of Science ®Google Scholar
• García Rodríguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006; 55:1538 - 44; http://dx.doi.org/10.1136/gut.2005.086579; PMID: 16785284
   PubMed Web of Science ®Google Scholar
• Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard DM, et al. Gastrin induces proliferation in Barrett’s metaplasia through activation of the CCK2 receptor. Gastroenterology 2003; 124:615 - 25; http://dx.doi.org/10.1053/gast.2003.50091; PMID: 12612900
   PubMed Web of Science ®Google Scholar
• Wang JS, Varro A, Lightdale CJ, Lertkowit N, Slack KN, Fingerhood ML, et al. Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett’s esophagus. Am J Gastroenterol 2010; 105:1039 - 45; http://dx.doi.org/10.1038/ajg.2009.629; PMID: 19904251
   PubMed Web of Science ®Google Scholar
• Takaishi S, Cui G, Frederick DM, Carlson JE, Houghton J, Varro A, et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 2005; 128:1965 - 83; http://dx.doi.org/10.1053/j.gastro.2005.03.027; PMID: 15940630
   PubMed Web of Science ®Google Scholar
• Jin G, Ramanathan V, Quante M, Baik GH, Yang X, Wang SS, et al. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J Clin Invest 2009; 119:2691 - 701; PMID: 19652364
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011; 140:1084 - 91; http://dx.doi.org/10.1053/j.gastro.2011.01.031; PMID: 21376940
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 2011; 140:e18 - 52, quiz e13; http://dx.doi.org/10.1053/j.gastro.2011.01.031; PMID: 21376939
   PubMedGoogle Scholar
• Winberg H, Lindblad M, Lagergren J, Dahlstrand H. Risk factors and chemoprevention in Barrett’s esophagus--an update. Scand J Gastroenterol 2012; 47:397 - 406; http://dx.doi.org/10.3109/00365521.2012.667145; PMID: 22428928
   PubMed Web of Science ®Google Scholar
• Kastelein F, Spaander MC, Biermann K, Vucelic B, Kuipers EJ, Bruno MJ. Role of acid suppression in the development and progression of dysplasia in patients with Barrett’s esophagus. Dig Dis 2011; 29:499 - 506; http://dx.doi.org/10.1159/000331513; PMID: 22095018
   PubMed Web of Science ®Google Scholar
• Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, et al. Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994-2006. Gut 2009; 58:182 - 8; http://dx.doi.org/10.1136/gut.2008.163360; PMID: 18978173
   PubMed Web of Science ®Google Scholar
• Barbera M, Fitzgerald RC. Cellular origin of Barrett’s metaplasia and oesophageal stem cells. Biochem Soc Trans 2010; 38:370 - 3; http://dx.doi.org/10.1042/BST0380370; PMID: 20298185
   PubMed Web of Science ®Google Scholar
• Hutchinson L, Stenstrom B, Chen D, Piperdi B, Levey S, Lyle S, et al. Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant. Stem Cells Dev 2011; 20:11 - 7; http://dx.doi.org/10.1089/scd.2010.0139; PMID: 20677919
   PubMed Web of Science ®Google Scholar
• Leedham SJPS, Preston SL, McDonald SA, Elia G, Bhandari P, Poller D, et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus. Gut 2008; 57:1041 - 8; http://dx.doi.org/10.1136/gut.2007.143339; PMID: 18305067
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105 - 11; http://dx.doi.org/10.1038/35102167; PMID: 11689955
   PubMed Web of Science ®Google Scholar
• Quante M, Wang TC. Stem cells in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2009; 6:724 - 37; http://dx.doi.org/10.1038/nrgastro.2009.195; PMID: 19884893
   PubMed Web of Science ®Google Scholar
• Quante M, Marrache F, Goldenring JR, Wang TC. TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa. Gastroenterology 2010; 139:2018 - 27, e2; http://dx.doi.org/10.1053/j.gastro.2010.08.003; PMID: 20708616
   PubMed Web of Science ®Google Scholar
• Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449:1003 - 7; http://dx.doi.org/10.1038/nature06196; PMID: 17934449
   PubMed Web of Science ®Google Scholar
• Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457:608 - 11; http://dx.doi.org/10.1038/nature07602; PMID: 19092804
   PubMed Web of Science ®Google Scholar
• Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459:262 - 5; http://dx.doi.org/10.1038/nature07935; PMID: 19329995
   PubMed Web of Science ®Google Scholar
• Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010; 6:25 - 36; http://dx.doi.org/10.1016/j.stem.2009.11.013; PMID: 20085740
   PubMed Web of Science ®Google Scholar
• Means AL, Xu Y, Zhao A, Ray KC, Gu GA. A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. Genesis 2008; 46:318 - 23; http://dx.doi.org/10.1002/dvg.20397; PMID: 18543299
   PubMed Web of Science ®Google Scholar
• Brembeck FH, Moffett J, Wang TC, Rustgi AK. The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology 2001; 120:1720 - 8; http://dx.doi.org/10.1053/gast.2001.24846; PMID: 11375953
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663 - 76; http://dx.doi.org/10.1016/j.cell.2006.07.024; PMID: 16904174
   PubMed Web of Science ®Google Scholar
• Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL, et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett’s metaplastic epithelium. Cancer Res 2001; 61:8284 - 9; PMID: 11719461
   PubMed Web of Science ®Google Scholar
• Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999; 22:106 - 9; http://dx.doi.org/10.1038/8816; PMID: 10319873
   PubMed Web of Science ®Google Scholar
• Leedham SJ, Preston SL, McDonald SA, Elia G, Bhandari P, Poller D, et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus. Gut 2008; 57:1041 - 8; http://dx.doi.org/10.1136/gut.2007.143339; PMID: 18305067
   PubMed Web of Science ®Google Scholar
• Nicholson AM, Graham TA, Simpson A, Humphries A, Burch N, Rodriguez-Justo M, et al. Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor. Gut 2011; PMID: 22200839
   PubMed Web of Science ®Google Scholar
• Giannakis M, Stappenbeck TS, Mills JC, Leip DG, Lovett M, Clifton SW, et al. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. J Biol Chem 2006; 281:11292 - 300; http://dx.doi.org/10.1074/jbc.M512118200; PMID: 16464855
   PubMed Web of Science ®Google Scholar
• Vega KJ, May R, Sureban SM, Lightfoot SA, Qu D, Reed A, et al. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol Hepatol 2012; 27:773 - 80; http://dx.doi.org/10.1111/j.1440-1746.2011.06928.x; PMID: 21916995
   PubMed Web of Science ®Google Scholar
• Riddell RH, Odze RD. Definition of Barrett’s esophagus: time for a rethink--is intestinal metaplasia dead?. Am J Gastroenterol 2009; 104:2588 - 94; http://dx.doi.org/10.1038/ajg.2009.390; PMID: 19623166
   PubMed Web of Science ®Google Scholar
• Menke V, van Es JH, de Lau W, van den Born M, Kuipers EJ, Siersema PD, et al. Conversion of metaplastic Barrett’s epithelium into post-mitotic goblet cells by gamma-secretase inhibition. Dis Model Mech 2010; 3:104 - 10; http://dx.doi.org/10.1242/dmm.003012; PMID: 20075383
   PubMed Web of Science ®Google Scholar
• Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax 1953; 8:87 - 101; http://dx.doi.org/10.1136/thx.8.2.87; PMID: 13077502
   PubMed Web of Science ®Google Scholar
• Barrett NR. Chronic peptic ulcer of the oesophagus and ‘oesophagitis’. Br J Surg 1950; 38:175 - 82; http://dx.doi.org/10.1002/bjs.18003815005; PMID: 14791960
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Yardley JH. Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977; 72:669 - 75; PMID: 838221
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Saka M, Eguchi T, Sekine S, Taniguchi H, Shimoda T. Distribution and significance of the oesophageal and gastric cardiac mucosae: a study of 131 operation specimens. Histopathology 2007; 51:515 - 9; http://dx.doi.org/10.1111/j.1365-2559.2007.02793.x; PMID: 17711448
   PubMed Web of Science ®Google Scholar
• Lembo TIA, Ippoliti AF, Ramers C, Weinstein WM. Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut 1999; 45:484 - 8; http://dx.doi.org/10.1136/gut.45.4.484; PMID: 10486352
   PubMed Web of Science ®Google Scholar
• Gatenby PA, Ramus JR, Caygill CP, Shepherd NA, Watson A. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus. Scand J Gastroenterol 2008; 43:524 - 30; http://dx.doi.org/10.1080/00365520701879831; PMID: 18415743
   PubMed Web of Science ®Google Scholar
• Takubo K, Vieth M, Aida J, Sawabe M, Kumagai Y, Hoshihara Y, et al. Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett’s adenocarcinoma, the definition of Barrett’s esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 2009; 80:248 - 57; http://dx.doi.org/10.1159/000235923; PMID: 19828957
   PubMed Web of Science ®Google Scholar
• Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, et al. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol 2006; 59:631 - 4; http://dx.doi.org/10.1136/jcp.2005.034298; PMID: 16731604
   PubMed Web of Science ®Google Scholar
• Harris JC, Clarke PA, Awan A, Jankowski J, Watson SA. An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett’s esophagus. Cancer Res 2004; 64:1915 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-03-2713; PMID: 15026323
   PubMed Web of Science ®Google Scholar
• Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR, Fitzgerald RC. Gastrin-induced cyclooxygenase-2 expression in Barrett’s carcinogenesis. Clin Cancer Res 2004; 10:4784 - 92; http://dx.doi.org/10.1158/1078-0432.CCR-04-0015; PMID: 15269153
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Greenwald BD, Peery AF, Dumot JA, Nishioka NS, Wolfsen HC, et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 2010; 71:680 - 5; http://dx.doi.org/10.1016/j.gie.2010.01.018; PMID: 20363409
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360:2277 - 88; http://dx.doi.org/10.1056/NEJMoa0808145; PMID: 19474425
   PubMed Web of Science ®Google Scholar
• Vaccaro BJ, Gonzalez S, Poneros JM, Stevens PD, Capiak KM, Lightdale CJ, et al. Detection of intestinal metaplasia after successful eradication of Barrett’s Esophagus with radiofrequency ablation. Dig Dis Sci 2011; 56:1996 - 2000; http://dx.doi.org/10.1007/s10620-011-1680-4; PMID: 21468652
   PubMed Web of Science ®Google Scholar
• Halsey KD, Chang JW, Waldt A, Greenwald BD. Recurrent disease following endoscopic ablation of Barrett’s high-grade dysplasia with spray cryotherapy. Endoscopy 2011; 43:844 - 8; http://dx.doi.org/10.1055/s-0030-1256649; PMID: 21826629
   PubMed Web of Science ®Google Scholar